Sona Nanotech Inc. (SONA.CN)
CAD 0.28
(-3.51%)
CAD 0.28
(-3.51%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.74 Million CAD | 427.73% |
| 2022 | 520.77 Thousand CAD | -65.81% |
| 2021 | 1.52 Million CAD | 110.22% |
| 2020 | 724.62 Thousand CAD | -15.66% |
| 2019 | 859.21 Thousand CAD | -72.96% |
| 2018 | 3.17 Million CAD | 83.1% |
| 2017 | 1.73 Million CAD | -64.23% |
| 2016 | 4.85 Million CAD | -48.55% |
| 2015 | 9.42 Million CAD | 4.93% |
| 2014 | 8.98 Million CAD | -11.73% |
| 2013 | 10.18 Million CAD | 12.83% |
| 2012 | 9.02 Million CAD | -29.54% |
| 2011 | 12.8 Million CAD | 24.8% |
| 2010 | 10.25 Million CAD | -4.11% |
| 2009 | 10.69 Million CAD | -41.95% |
| 2008 | 18.43 Million CAD | 32.59% |
| 2007 | 13.9 Million CAD | 547.34% |
| 2006 | 2.14 Million CAD | 816460.08% |
| 2005 | 263.00 CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 2 Million CAD | -10.36% |
| 2024 Q2 | 2.23 Million CAD | -12.8% |
| 2024 Q1 | 2.56 Million CAD | -6.75% |
| 2023 Q4 | 2.74 Million CAD | -10.8% |
| 2023 Q3 | 3.08 Million CAD | -14.35% |
| 2023 FY | 2.74 Million CAD | 427.73% |
| 2023 Q2 | 3.59 Million CAD | 1198.99% |
| 2023 Q1 | 276.9 Thousand CAD | -46.83% |
| 2022 Q1 | 1.54 Million CAD | 1.1% |
| 2022 FY | 520.77 Thousand CAD | -65.81% |
| 2022 Q4 | 520.77 Thousand CAD | -20.74% |
| 2022 Q3 | 657.03 Thousand CAD | -37.99% |
| 2022 Q2 | 1.05 Million CAD | -31.19% |
| 2021 Q1 | 2.02 Million CAD | 179.47% |
| 2021 FY | 1.52 Million CAD | 110.22% |
| 2021 Q2 | 2.34 Million CAD | 15.83% |
| 2021 Q4 | 1.52 Million CAD | -29.85% |
| 2021 Q3 | 2.17 Million CAD | -7.42% |
| 2020 Q2 | 1.75 Million CAD | 228.65% |
| 2020 FY | 724.62 Thousand CAD | -15.66% |
| 2020 Q1 | 535.52 Thousand CAD | -37.67% |
| 2020 Q4 | 724.62 Thousand CAD | -56.94% |
| 2020 Q3 | 1.68 Million CAD | -4.39% |
| 2019 Q3 | 1.4 Million CAD | -43.74% |
| 2019 Q1 | 2.76 Million CAD | -12.95% |
| 2019 Q4 | 859.21 Thousand CAD | -38.95% |
| 2019 FY | 859.21 Thousand CAD | -72.96% |
| 2019 Q2 | 2.5 Million CAD | -9.57% |
| 2018 Q4 | 3.17 Million CAD | 98.19% |
| 2018 FY | 3.17 Million CAD | 83.1% |
| 2018 Q1 | 1.83 Million CAD | 5.81% |
| 2018 Q2 | 1.63 Million CAD | -11.19% |
| 2018 Q3 | 1.6 Million CAD | -1.69% |
| 2017 Q3 | 4.91 Million CAD | 8.72% |
| 2017 Q2 | 4.52 Million CAD | -3.27% |
| 2017 Q1 | 4.67 Million CAD | -3.62% |
| 2017 FY | 1.73 Million CAD | -64.23% |
| 2017 Q4 | 1.73 Million CAD | -64.7% |
| 2016 Q3 | 5.26 Million CAD | -33.07% |
| 2016 Q1 | 9.51 Million CAD | 0.91% |
| 2016 Q4 | 4.85 Million CAD | -7.82% |
| 2016 Q2 | 7.86 Million CAD | -17.36% |
| 2016 FY | 4.85 Million CAD | -48.55% |
| 2015 Q2 | 9.2 Million CAD | 3.52% |
| 2015 FY | 9.42 Million CAD | 4.93% |
| 2015 Q1 | 8.89 Million CAD | -1.04% |
| 2015 Q4 | 9.42 Million CAD | -1.07% |
| 2015 Q3 | 9.52 Million CAD | 3.53% |
| 2014 Q2 | 10.1 Million CAD | -0.59% |
| 2014 Q4 | 8.98 Million CAD | -9.4% |
| 2014 Q3 | 9.91 Million CAD | -1.88% |
| 2014 Q1 | 10.16 Million CAD | -0.11% |
| 2014 FY | 8.98 Million CAD | -11.73% |
| 2013 Q4 | 10.18 Million CAD | 13.12% |
| 2013 FY | 10.18 Million CAD | 12.83% |
| 2013 Q3 | 8.99 Million CAD | -1.6% |
| 2013 Q2 | 9.14 Million CAD | 3.85% |
| 2013 Q1 | 8.8 Million CAD | -2.4% |
| 2012 Q4 | 9.02 Million CAD | -1.39% |
| 2012 Q3 | 9.14 Million CAD | 7.75% |
| 2012 Q2 | 8.49 Million CAD | 1.09% |
| 2012 Q1 | 8.39 Million CAD | -34.4% |
| 2012 FY | 9.02 Million CAD | -29.54% |
| 2011 Q3 | 11.03 Million CAD | 0.41% |
| 2011 FY | 12.8 Million CAD | 24.8% |
| 2011 Q1 | 10.38 Million CAD | 1.26% |
| 2011 Q4 | 12.8 Million CAD | 16.05% |
| 2011 Q2 | 10.98 Million CAD | 5.77% |
| 2010 FY | 10.25 Million CAD | -4.11% |
| 2010 Q1 | 10.53 Million CAD | -1.54% |
| 2010 Q2 | 10.35 Million CAD | -1.73% |
| 2010 Q3 | 10.26 Million CAD | -0.87% |
| 2010 Q4 | 10.25 Million CAD | -0.03% |
| 2009 FY | 10.69 Million CAD | -41.95% |
| 2009 Q2 | 11.09 Million CAD | -38.53% |
| 2009 Q3 | 11.9 Million CAD | 7.33% |
| 2009 Q1 | 18.04 Million CAD | -2.09% |
| 2009 Q4 | 10.69 Million CAD | -10.15% |
| 2008 Q2 | 19.34 Million CAD | -5.98% |
| 2008 FY | 18.43 Million CAD | 32.59% |
| 2008 Q4 | 18.43 Million CAD | -3.69% |
| 2008 Q1 | 20.57 Million CAD | 47.98% |
| 2008 Q3 | 19.13 Million CAD | -1.06% |
| 2007 Q1 | 4.48 Million CAD | 108.99% |
| 2007 Q3 | 13.91 Million CAD | -2.4% |
| 2007 Q2 | 14.25 Million CAD | 217.71% |
| 2007 Q4 | 13.9 Million CAD | -0.11% |
| 2007 FY | 13.9 Million CAD | 547.34% |
| 2006 Q3 | 2.55 Million CAD | 76.56% |
| 2006 Q2 | 1.44 Million CAD | 658290.45% |
| 2006 Q4 | 2.14 Million CAD | -16.02% |
| 2006 FY | 2.14 Million CAD | 816460.08% |
| 2006 Q1 | 220.00 CAD | 0.0% |
| 2005 FY | 263.00 CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| BioMark Diagnostics Inc. | 1.08 Million CAD | -152.383% |
| Izotropic Corporation | 232.37 Thousand CAD | -1082.674% |